213 related articles for article (PubMed ID: 21086121)
1. Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors.
Maleno I; Aptsiauri N; Cabrera T; Gallego A; Paschen A; López-Nevot MA; Garrido F
Immunogenetics; 2011 Feb; 63(2):65-71. PubMed ID: 21086121
[TBL] [Abstract][Full Text] [Related]
2. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
[TBL] [Abstract][Full Text] [Related]
3. The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma.
Paschen A; Arens N; Sucker A; Greulich-Bode KM; Fonsatti E; Gloghini A; Striegel S; Schwinn N; Carbone A; Hildenbrand R; Cerwenka A; Maio M; Schadendorf D
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3297-305. PubMed ID: 16740750
[TBL] [Abstract][Full Text] [Related]
4. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
[TBL] [Abstract][Full Text] [Related]
6. High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis.
Koene GJ; Arts-Hilkes YH; van der Ven KJ; Rozemuller EH; Slootweg PJ; de Weger RA; Tilanus MG
Tissue Antigens; 2004 Oct; 64(4):452-61. PubMed ID: 15361122
[TBL] [Abstract][Full Text] [Related]
7. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
[TBL] [Abstract][Full Text] [Related]
8. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
[TBL] [Abstract][Full Text] [Related]
10. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.
McEvoy CR; Seshadri R; Morley AA; Firgaira FA
Tissue Antigens; 2002 Sep; 60(3):235-43. PubMed ID: 12445306
[TBL] [Abstract][Full Text] [Related]
11. LOH in the HLA class I region at 6p21 is associated with shorter survival in newly diagnosed adult glioblastoma.
Yeung JT; Hamilton RL; Ohnishi K; Ikeura M; Potter DM; Nikiforova MN; Ferrone S; Jakacki RI; Pollack IF; Okada H
Clin Cancer Res; 2013 Apr; 19(7):1816-26. PubMed ID: 23401227
[TBL] [Abstract][Full Text] [Related]
12. Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; Cabrera CM; Cabrera T; Paco L; López-Nevot MA; Collado A; Ferrón A; Garrido F
Immunogenetics; 2004 Jul; 56(4):244-53. PubMed ID: 15258706
[TBL] [Abstract][Full Text] [Related]
13. LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
Maleno I; Romero JM; Cabrera T; Paco L; Aptsiauri N; Cozar JM; Tallada M; López-Nevot MA; Garrido F
Immunogenetics; 2006 Jul; 58(7):503-10. PubMed ID: 16705407
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
Jimenez P; Cantón J; Concha A; Cabrera T; Fernández M; Real LM; García A; Serrano A; Garrido F; Ruiz-Cabello F
Cancer Immunol Immunother; 2000 Mar; 48(12):684-90. PubMed ID: 10752476
[TBL] [Abstract][Full Text] [Related]
15. Beta2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system.
Jordanova ES; Riemersma SA; Philippo K; Schuuring E; Kluin PM
Int J Cancer; 2003 Jan; 103(3):393-8. PubMed ID: 12471623
[TBL] [Abstract][Full Text] [Related]
16. Copy Neutral LOH Affecting the Entire Chromosome 6 Is a Frequent Mechanism of
Garrido MA; Perea F; Vilchez JR; Rodríguez T; Anderson P; Garrido F; Ruiz-Cabello F; Aptsiauri N
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680201
[TBL] [Abstract][Full Text] [Related]
17. Beta2-microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors.
Fernández MA; Ruiz-Cabello F; Oliva MR; Cabrera T; Jimenez P; López Nevot MA; Garrido F
Int J Clin Lab Res; 2000; 30(2):87-92. PubMed ID: 11043502
[TBL] [Abstract][Full Text] [Related]
18. Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genes.
Hsieh CH; Hsu YJ; Chang CC; Liu HC; Chuang KL; Chuang CK; Pang ST; Hasumi K; Ferrone S; Liao SK
Cancer Immunol Immunother; 2009 Mar; 58(3):395-408. PubMed ID: 18704411
[TBL] [Abstract][Full Text] [Related]
19. Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas.
Maleno I; Lopez Nevot MA; Seliger B; Garrido F
Int J Cancer; 2004 Apr; 109(4):636-8. PubMed ID: 14991587
[TBL] [Abstract][Full Text] [Related]
20. Molecular strategies to define HLA haplotype loss in microdissected tumor cells.
Ramal LM; Maleno I; Cabrera T; Collado A; Ferron A; Lopez-Nevot MA; Garrido F
Hum Immunol; 2000 Oct; 61(10):1001-12. PubMed ID: 11082513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
